Clinical Trial Update: Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 neoadjuvant trial of atezolizumab for surgically resectable advanced cutaneous squamous cell carcinoma, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Tecentriq (atezolizumab)

Snippet

Sponsor: Stanford University | Conditions: Cutaneous Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-02-03